Do patients participating in clinical trials want to know study results? [4]

Journal of the National Cancer Institute

Volumn 95, Issue 6, 2003, Pages 491-492

  Partridge, Ann H ^a   Burstein, Harold J ^a   Gelman, Rebecca S ^a   Marcom, P Kelly ^b   Winer, Eric P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER PATIENT; CANCER RESEARCH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; LETTER; MEDICAL ASSESSMENT; MEDICAL ETHICS; MEDICAL RESEARCH; NURSE; OUTCOMES RESEARCH; PATIENT ATTITUDE; PATIENT CARE; PATIENT EDUCATION; PATIENT RIGHT; PATIENT SATISFACTION; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; RELATIVE; TELEPHONE;

EID: 0037454241     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/95.6.491     Document Type: Letter

References (5)

1. Partridge AH, Winer EP. Informing clinical trial participants about study results. JAMA 2002;288:363-5.
2. Coalition of National Cancer Cooperative Groups, Inc. Guidelines for notifying patients about early closure of cancer clinical trials. 2002. [Last accessed: 02/11/2003.] Available at: www.cancertrialshelp.org/patientAdvocates/policies.jsp.
3. Cancer Leadership Counsel, Cancer Research Foundation of America, Coalition of National Cancer Cooperative Groups, and the Oncology Nursing Society. The Summit Series on Clinical Trials. Increasing Patient Participation. [Last accessed: 02/11/2003.] Available at: http://www.cancersummit.com/pdfs/summit_iii_report.pdf.
4. Burstein HJ, Kuter I, Campos SM, Gelman RS, Tribou L, Parker LM, et al. Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer. J Clin Oncol 2001;19:2722-30.
5. Shurin S. Bioethics Committee: report and invitation. Child Oncol News 2001;2:14.